pandem
rapidli
spread
throughout
world
recent
report
suggest
infect
patient
asymptomat
studi
report
subject
signific
viral
shed
prior
symptom
onset
sinc
asymptomat
presymptomat
subject
spread
diseas
identifi
individu
critic
effect
control
pandem
therefor
urgent
need
increas
diagnost
test
capabl
order
also
screen
asymptomat
carrier
fact
test
routin
requir
vaccin
develop
yet
major
bottleneck
manag
pandem
mani
countri
diagnost
test
due
limit
laboratori
capabl
well
limit
access
genomeextract
polymeras
chain
reaction
pcr
reagent
develop
pbest
method
poolingbas
effici
test
use
nonadapt
grouptest
approach
significantli
reduc
number
test
requir
identifi
posit
subject
within
larg
set
sampl
instead
test
sampl
separ
sampl
pool
group
pool
test
use
standard
clinic
approv
pcrbase
diagnost
assay
sampl
part
multipl
pool
use
combinatori
pool
strategi
base
compress
sens
design
maxim
abil
identifi
posit
individu
evalu
pbest
use
leftov
sampl
previous
clinic
test
current
proofofconcept
studi
pool
patient
sampl
pool
provid
increas
test
effici
five
set
sampl
contain
posit
carrier
screen
posit
carrier
set
correctli
identifi
pbest
provid
effici
easytoimpl
solut
increas
test
capac
work
clinic
approv
genomeextract
pcrbase
diagnost
methodolog
pandem
rapidli
spread
throughout
world
recent
report
suggest
infect
patient
asymptomat
studi
report
subject
signific
viral
shed
prior
symptom
onset
sinc
asymptomat
presymptomat
subject
spread
diseas
identifi
individu
critic
effect
control
pandem
major
bottleneck
manag
pandem
mani
countri
diagnost
test
primarili
perform
symptomat
patient
due
limit
laboratori
capabl
well
limit
access
genomeextract
polymeras
chain
reaction
pcr
reagent
henc
urgent
need
increas
diagnost
test
capabl
order
allow
screen
asymptomat
popul
contribut
diseas
spread
fact
test
routin
requir
vaccin
develop
percentag
carrier
test
set
sampl
suffici
low
method
correctli
identifi
posit
individu
use
much
smaller
number
diagnost
test
compar
test
individu
sampl
separ
develop
pbest
method
poolingbas
effici
test
use
grouptest
approach
significantli
reduc
number
test
requir
identifi
posit
subject
within
larg
set
sampl
figur
instead
test
sampl
separ
sampl
pool
group
pool
test
use
standard
clinic
approv
pcrbase
diagnost
assay
sampl
part
multipl
pool
use
combinatori
pool
strategi
design
maxim
abil
identifi
posit
individu
figur
percentag
carrier
test
set
sampl
suffici
low
method
correctli
identifi
posit
individu
use
much
smaller
number
diagnost
test
compar
test
individu
sampl
separ
current
proofofconcept
studi
pbest
pool
patient
sampl
pool
contain
sampl
sampl
ad
six
differ
pool
pool
design
base
reedsolomon
error
correct
code
gener
use
autom
liquid
dispens
robot
follow
genomeextract
pcr
amplif
pool
decod
algorithm
use
identifi
carrier
test
individu
verif
total
time
pool
sampl
pool
use
basic
liquid
dispens
robot
aris
hour
perform
standard
laboratori
sinc
individu
sampl
dilut
lysi
buffer
inactiv
viral
particl
evalu
pbest
use
leftov
sampl
previous
clinic
test
sampl
dilut
lysi
buffer
pool
pool
contain
set
uniqu
sampl
pool
sampl
test
clinic
diagnost
laboratori
soroka
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
univers
medic
center
use
clinic
approv
pcrbase
diagnost
protocol
includ
rna
extract
stage
test
pbest
use
four
set
sampl
contain
increas
number
posit
carrier
rang
two
five
found
pbest
abl
correctli
identifi
posit
carrier
within
four
set
sampl
use
test
per
set
provid
increas
test
effici
simul
demonstr
method
correctli
identifi
carrier
averag
number
fals
posit
less
averag
number
fals
neg
less
pbest
provid
effici
easytoimpl
solut
increas
test
capac
work
clinic
approv
genomeextract
pcrbase
diagnost
methodolog
implement
requir
use
wide
avail
autom
liquid
dispens
robot
importantli
result
demonstr
pbest
use
noninfecti
sampl
dilut
lysi
buffer
allow
autom
pool
perform
laboratori
current
pool
design
provid
increas
test
effici
improv
increas
number
sampl
per
pool
preliminari
experi
demonstr
posit
sampl
detect
even
within
pool
subject
would
allow
effici
test
sampl
pbest
optim
effici
test
popul
low
carrier
frequenc
case
therefor
best
suit
screen
asymptomat
popul
high
risk
infect
exclud
exampl
subject
close
contact
confirm
case
importantli
carrier
frequenc
pbest
lose
effici
turn
may
help
identifi
hotspot
code
protocol
requir
implement
pbest
found
http
githubcomnoamshentalpbest
thank
avishai
edri
aner
ottolenghi
yariv
greenshpan
help
sampl
prepar
rna
measur
thank
dr
rachel
steinberg
help
diagnost
test
thank
jenni
racah
shelli
levytzedek
construct
discuss
manuscript
edit
noam
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
follow
incub
use
nucleic
acid
extract
volum
extract
genom
taken
pcr
assay
frozen
leftov
medialysi
buffer
near
clinic
test
sampl
thaw
use
retest
sampl
use
pbest
approach
test
sensit
method
gener
sever
set
sampl
contain
posit
sampl
respect
pool
prepar
use
liquid
handl
robot
aris
use
code
written
python
code
automat
gener
command
file
robot
use
sampl
manual
pipet
well
plate
robot
assembl
set
pool
contain
distinct
sampl
gener
pool
sampl
set
pool
contain
equal
volum
sampl
sampl
per
pool
individu
sampl
repres
six
differ
pool
analog
singl
sampl
pool
use
nucleic
acid
extract
volum
use
clinic
approv
starmag
kit
starlet
robot
use
qrtpcr
detect
e
gene
base
method
clinic
valid
employ
sumcclin
virolog
laboratori
prior
introduct
seegen
kit
use
pcr
method
due
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
shortag
assay
kit
seegen
yet
verifi
compet
newli
approv
assay
kit
revalid
posit
pool
seegen
kit
sinc
pbest
sampl
dilut
pool
subject
inher
drop
pcr
sensit
cycl
factor
inde
observ
experiment
may
result
fals
neg
pool
retrospect
analysi
found
singl
pool
includ
carrier
yield
neg
pcr
result
expect
posit
pool
across
four
experi
similarli
neg
pool
posit
identifi
pcrbase
assay
two
error
effect
detect
capabl
pbest
robust
type
error
sinc
proofofconcept
experi
use
sampl
posit
individu
previous
identifi
observ
addit
drop
pcr
sensit
like
caus
rna
degrad
sampl
follow
freezethaw
cycl
confirm
test
sever
individu
sampl
freezethaw
cycl
observ
similar
drop
pcr
sensit
howev
pbest
still
abl
correctli
identifi
posit
subject
within
sampl
set
note
reduct
occur
pbest
implement
fresh
sampl
collect
directli
lysi
buffer
per
current
experiment
protocol
address
sensit
issu
propos
modifi
sampl
collect
protocol
collect
sampl
directli
lysi
buffer
therebi
increas
initi
concentr
rna
collect
sampl
test
pbest
pool
sampl
use
seegen
pcr
kit
also
includ
primer
np
gene
preliminari
experi
higher
sensit
compar
gene
includ
kit
posit
even
dilut
singl
posit
sampl
pool
subject
supplement
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
pbest
best
suit
screen
asymptomat
popul
carrier
frequenc
may
suffici
low
allow
effici
detect
scenario
includ
routin
screen
healthcar
worker
staff
nurs
home
well
popul
screen
differ
region
identifi
new
hotspot
spread
earli
possibl
note
addit
pool
design
may
implement
estim
carrier
frequenc
given
popul
may
identifi
specif
scenario
pbest
use
mathemat
field
group
test
aim
tackl
problem
identifi
individu
carri
certain
rare
trait
larg
popul
design
effici
set
pool
measur
pool
singl
sampl
gener
pool
design
way
individu
uniqu
footprint
set
pool
thu
allow
carrier
identif
group
test
date
back
centuri
sinc
mani
intric
pool
design
describ
rigor
analyz
group
test
success
appli
data
compress
comput
data
stream
model
molecular
biolog
previou
studi
describ
combin
group
test
next
gener
sequenc
detect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
carrier
rare
genet
mutat
detect
individu
carrier
rare
mutat
set
mutagen
sorghum
bicolor
plant
use
set
pool
effici
group
test
often
measur
ratio
number
screen
individu
number
pool
gener
increas
decreas
frequenc
observ
trait
exampl
screen
trait
appear
popul
done
effici
screen
trait
appear
popul
moreov
carrier
rate
exce
group
test
longer
effect
sinc
requir
number
pool
would
compar
number
sampl
test
optim
effici
pool
design
need
tailor
expect
carrier
rate
true
carrier
rate
exce
expect
rate
method
identifi
larger
set
suspect
carrier
may
includ
fals
posit
case
may
also
fail
identifi
carrier
fals
neg
therefor
imper
evalu
robust
specif
pool
design
higher
carrier
rate
eg
figur
supplement
figur
current
detect
strategi
base
binari
result
pool
ie
pool
either
amplifi
sinc
pcr
result
quantit
may
possibl
use
inform
pbest
reconstruct
algorithm
also
estim
c
valu
carrier
proport
individu
viral
load
may
clinic
relev
carrier
detect
perform
use
gradient
project
spars
reconstruct
gpsr
algorithm
former
studi
transform
fraction
discret
result
done
use
follow
algorithm
sampl
highest
score
select
subset
consid
total
subset
sampl
test
subset
correspond
vector
length
entri
select
sampl
equal
other
set
zero
product
pool
matrix
compar
measur
vector
vector
achiev
minimum
select
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
test
robust
pbest
consid
two
type
potenti
nois
factor
first
variat
initi
rna
level
may
caus
sampl
disappear
part
pool
variat
rna
level
estim
qubit
measur
sampl
averag
rna
concentr
standard
deviat
supplement
figur
valu
use
simul
second
possibl
sourc
nois
due
pcr
amplif
may
fail
certain
number
pool
supplement
assess
effect
variat
rna
level
measur
averag
number
fals
posit
fals
neg
detect
function
true
number
carrier
across
simul
two
scenario
nois
rna
level
black
squar
rna
nois
base
measur
variat
rna
level
across
sampl
see
supplement
figur
fals
posit
left
panel
fals
neg
right
panel
detect
rate
two
scenario
show
rna
variat
significantli
degrad
pbest
perform
simul
consid
one
drop
pool
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
supplement
figur
evalu
effect
drop
pool
pbest
perform
assess
effect
drop
pool
due
pcr
amplif
failur
measur
averag
number
fals
posit
left
panel
fals
neg
right
panel
detect
function
true
number
carrier
across
simul
zero
one
two
randomli
drop
pool
pbest
seem
robust
drop
pool
simul
consid
experiment
level
rna
variat
measur
across
sampl
supplement
figur
multipl
recent
studi
identifi
asymptomat
carrier
attempt
estim
rate
contribut
diseas
spread
studi
tourist
new
york
area
conduct
two
season
found
subject
test
posit
least
one
respiratori
viru
infect
circul
human
corona
virus
roth
et
al
describ
transmiss
german
patient
infect
chines
businesswoman
visit
germani
importantli
asymptomat
visit
germani
develop
symptom
return
china
two
german
cowork
infect
came
contact
german
patient
asymptomat
mizumoto
et
al
report
infect
patient
board
diamond
princess
cruis
ship
asymptomat
time
diagnosi
use
model
estim
estim
asymptomat
proport
among
infect
case
cri
anoth
studi
evacu
japanes
nation
wuhan
china
estim
subject
asymptomat
ci
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
